Demonstrates a novel formulation of furosemide for safe management of cardiovascular disorders in neonates, indicating potential benefits.
Oral furosemide suspensions prepared with xanthan gum exhibited satisfactory physicochemical and microbiological stability. These neonatal formulations show potential for the safe management of pediatric cardiovascular disorders.
No takes yet. Share an insight, caveat, or question.
Soutier et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: